Nanotechnology Now - Press Release: "Dr. Raul Pires appointed as new head of Carbon Nanotubes & Nanoproducts at Bayer MaterialScience as of September 1st, 2009"

Home > Press > Dr. Raul Pires appointed as new head of Carbon Nanotubes & Nanoproducts at Bayer MaterialScience as of September 1st, 2009

Dr. Raul Pires

Dr. Raul Pires

Abstract:
As of September 1st Dr. Raul Pires took over the responsibilities for the activities on Carbon Nanotubes & Nanoproducts at Bayer MaterialScience (BMS) 2009 from Martin Schmid.

Dr. Raul Pires appointed as new head of Carbon Nanotubes & Nanoproducts at Bayer MaterialScience as of September 1st, 2009

EU | Posted on November 23rd, 2009

The former scope based on carbon nanotubes and Baytubes was thereby additionally expanded by the nano-modified coatings and adhesives raw materials activities.

Prior to his current assignment, Dr. Raul Pires headed the Business Development group of the Coatings, Adhesives and Specialties raw materials business unit of BMS for Asia Pacific from 2006 to August 2009 in Shanghai/P.R. China.

Dr. Pires joined Bayer in 1997 and has since then worked in several different technical and commercial positions such as lab manager coatings, product manager and senior sales manager Europe.

####

About Bayer MaterialScience AG
Bayer MaterialScience AG is an independent, globally operating company within the Bayer Group. The name Bayer MaterialScience stands for the materials that the company develops and produces. It also stands for the know-how and expertise of its employees all over the world.

Bayer MaterialScience employs around 15,100 employees at 30 locations throughout the world. Sales of some 9.7 billion euros were achieved in 2008.

Bayer MaterialScience is currently making major investments in the boom region of Asia. The integrated site in Shanghai is being expanded by Bayer into the group’s largest and most technically advanced production site in the region. The total investment planned for this site up until 2012 amounts to EUR 2.1 billion, EUR 0.7 billion of which are scheduled for the period from 2009 until 2012.

For more information, please click here

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: